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Abstract
Attention Deficit/Hyperactivity Disorder (ADHD) is a common neuropsychiatric disorder that has not been well studied in
older adults. In this study we examined relationships between ADHD symptoms and cognitive ability and compared them
between middle-age (MA; 48–52 years) and older-age (OA; 68–74 years) adults sampled from the same population. ADHD,
mood disorder symptoms and cognitive abilities were assessed in a large population-based sample (n = 3443; 50% male).
We measured current ADHD symptoms using the adult ADHD Self-Report Scale (ASRS), which we found to have the same
underlying structure in both cohorts. Older adults reported significantly lower levels of ADHD symptoms and 2.2% of the OA
cohort scored equal or above the ASRS cut-off score of 14 (which has been previously associated with ADHD diagnosis)
compared with 6.2% of MA adults. Symptom levels were not significantly different between males and females. Using multi-
group structural equation modelling we compared ADHD symptom–cognitive performance relationships between the two
age groups. Generally higher ADHD symptoms were associated with poorer cognitive performance in the MA cohort.
However, higher levels of inattention symptoms were associated with better verbal ability in both cohorts. Surprisingly,
greater hyperactivity was associated with better task-switching abilities in older adults. In the OA cohort ADHD symptom–
cognition relationships are indirect, mediated largely through the strong association between depression symptoms and
cognition. Our results suggest that ADHD symptoms decrease with age and that their relationships with co-occurring mood
disorders and cognitive performance also change. Although symptoms of depression are lower in older adults, they are
much stronger predictors of cognitive performance and likely mediate the effect of ADHD symptoms on cognition in this
age group. These results highlight the need for age-appropriate diagnosis and treatment of comorbid ADHD and mood
disorders.
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Introduction
Attention Deficit/Hyperactivity Disorder (ADHD) is a neuro-
psychiatric disorder that develops in childhood and can persist
throughout life. It is characterised by age-inappropriate levels of
inattention and/or excessive motor activity and impulsivity [1]. In
adults inattention is the predominant symptom, which manifests as
disorganization, forgetfulness, unreliability, and poor performance
in planning, task completion, task shifting and time management.
ADHD symptoms affect functioning in multiple life domains often
leading to employment and financial difficulties, and interpersonal
problems [2,3]. ADHD is associated with cognitive impairment in
both children and adults [4–10]. Furthermore, individuals with
ADHD are more likely than unaffected individuals to experience
comorbid psychiatric disorders [2,11]. The majority of adult with
ADHD have at least one lifetime psychiatric comorbidity
including anxiety (47%), mood (38%), impulse control (20%)
and substance use disorders (15%) [12]. The high level of
comorbidity has raised questions about whether the functional
impairments in ADHD patients are primarily due to ADHD or
the comorbid conditions. Addressing this issue a recent study
reported that neuropsychological deficits in ADHD adults go
beyond comorbidity [13]. The financial burden of ADHD on
families and society is substantial due to direct medical expenses
and the indirect costs of workplace productivity loss and accidents
[14–18]. Furthermore, the negative impact of ADHD symptoms/
impairments on professional, economic, social, and emotional
well-being accumulates through life affecting quality of life at late-
age [19].
ADHD Prevalence in Late-life
ADHD is a common disorder affecting ,5% of children and 1–
7% of adults [20–25]. The prevalence of the disorder is thought to
diminish with age [3]. However, very little is known about ADHD
in late life since most studies on adult ADHD have focussed on
young adults. Kooij et al (2005) [26] estimated the prevalence of
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ADHD among older adults (18–75 years) in the Netherlands to be
1–2.5%. The study by Michielsen et al. (2012) [27] reported
prevalence rates of 2.8% and 4.2% for syndromatic and
symptomatic ADHD, respectively, in adults aged 60–94 years. It
is important to note that diagnostic criteria currently used for
ADHD were developed for children and adolescents. It is
uncertain how well these diagnostic criteria and thresholds apply
to adults since the symptom patterns change with age [3].
Following recent recommendations [28], symptom threshold have
been lowered for adults in the Diagnostic and Statistical Manual of
Mental Disorders (5th ed; DSM-5; [29]). Furthermore, DSM-based
diagnosis of adult ADHD requires symptoms to be present in
childhood – before 7 years in DSM-IV and before 12 years in
DSM-5. Hence, diagnosis of ADHD in adults depends on accurate
recall of childhood symptoms, which can be challenging for older
adults. Thus, while it is accepted that ADHD persists throughout
life, the condition is not well understood in old age and its
prevalence is uncertain.
ADHD Dimensionality
Although ADHD remains a categorically distinct clinical
condition, there is increasing recognition that clinical ADHD lies
at the extreme ends of the distribution of continuous ADHD
symptom dimensions. Furthermore, symptoms of ADHD are
common and can lead to functional impairment in adults who do
not meet all the criteria for clinical diagnosis [2,30]. A dimensional
view is supported by evidences from several taxonomic, genetic
and neuroimaging studies [31–34]. The majority of these studies
are of childhood ADHD, but a recent taxonomic study in a sample
of young adults also indicates a dimensional latent structure of
ADHD in adults [35]. It is also well-established that ADHD is
characterised by two related but distinct dimensions – inattention
and hyperactivity [36], which have distinctive brain and cognitive
characteristics [37–39]. The specific behavioural and cognitive
characteristics of these dimensions are poorly understood. Their
relative importance changes with age, with inattention becoming
more dominant in adults, which may have an important impact on
how the cognitive effects of ADHD change with age.
Cognitive and Functional Consequence of Adult ADHD
Cognitive deficits have been consistently identified in both
children and adults with ADHD [4–10]. Compared to unaffected
individuals ADHD adults are cognitively different across multiple
functional domains, with notable differences in attention, behav-
ioural inhibition and non-executive functional aspects of memory,
processing speed and motor speed [40–42]. Meta-analyses have
also reported slightly lower IQ in adults with ADHD [40,41,43].
Neuropsychological research in ADHD has focussed primarily on
aspects of attention and executive functions with multiple studies
demonstrating deficits in vigilance, selective attention, distractibil-
ity, divided attention and flexibility, working memory, set shifting
and planning [44–49]. Few such studies have been conducted in
middle-aged or older adults. From a cross-sectional study of 116
non-medicated ADHD patients 19–55 years of age, Biederman
et al. (2011) concluded that the negative impact of ADHD on
cognition remains constant across the lifespan [50]. In another
study, cognitive test profiles in older adults (62–91 years of age)
were found to be associated with reports of childhood ADHD [51].
Using dimensional measures of ADHD symptoms we have
previously reported that inattention and hyperactivity symptoms
are associated with cognitive performance measures in middle-
aged adults (47–54 years) [52]. Symptoms of inattention in
particular were associated with poorer performance in this age
group. Furthermore, some but not all of the effects of ADHD
symptoms on cognition were mediated through co-occurring
anxiety and depression symptoms. Thus, a very limited number of
studies indicate that ADHD has a negative impact on cognitive
functioning in old age, but the extent and nature of the impact is
not well understood.
The Present Study
In this study we extend our analyses of ADHD symptoms to a
cohort of older adults (68–72 years) in the Personality and Total
Health (PATH) Through Life Study, a population-based longitu-
dinal study of mental health and ageing [53]. We focus on the
association of ADHD symptoms with cognitive performance
measures. To assess ADHD symptoms we used the adult ADHD
Self-Report Scale (ASRS) [54], which is a checklist of inattention
and hyperactivity symptoms based on the diagnostic criteria
outlined in the DSM-IV-Text Revision. The ASRS demonstrated
good sensitivity and specificity in clinical validation studies and is
recommended for use in epidemiological studies [55]. However,
the ASRS has not been validated in older adults. Hence, the first
aim of the present study was to test whether the ASRS has the
same underlying measurement properties in our middle-age (MA)
and older-age (OA) cohorts. The second aim of the study was to
examine whether relationships between ASRS latent factors
(inattention and hyperactivity) and cognitive performance differ
between the age groups. As a part of the second aim we also
examined whether co-occurring anxiety and depression symptoms
affect ADHD symptom–cognition relationships differently in
middle- and older-age cohorts. Based on previous evidence of
decrease in ADHD prevalence with age we expected participants
in the older cohort to report fewer ADHD symptoms than middle-
aged participants. Guided by our previous work on the middle-
aged adults [52] we expected cognitive performance to be




The study sample was drawn from the PATH Through Life
Project, a large longitudinal study of mental health and ageing in
participants across three age groups (20–24, 40–44, 60–64 years at
baseline) with a four-yearly follow-up ‘waves’ of assessment for up
to 20 years [53]. The baseline sample comprised of individuals
selected randomly from the electoral roll from the city of Canberra
and the adjacent town of Queanbeyan, Australia (which provides a
representative population sample because enrolment to vote is a
legal requirement for adult Australian citizens).
The present study used data from the third wave of assessment
(the ASRS was introduced in this wave) of the MA (40–44 years at
baseline) and OA (60–64 years at baseline) cohorts. There were
2182 participants in MA cohort aged 48–52 years (mean age
50.761.5 years) and 1973 individuals in the OA cohort aged 68–
72 years (mean age 70.661.5 years). Twenty-six (1%) and fifty-
three participants (2.8%) in the MA and OA cohorts respectively
did not complete the ASRS questionnaire and were excluded from
further analysis. Being older was associated with increased odds of
not completing the questionnaire in the OA cohort. However,
non-responders did not differ significantly (p.0.05) from respond-
ers with respect to gender, total years of education and the levels of
anxiety or depression symptoms in either cohort. Participants
meeting at least one of the following criteria – history of epilepsy,
brain tumour/infection and stroke and with missing data were
excluded. Mini Mental State Examination (MMSE) was included
in the assessment of the OA cohort to screen for probable
ADHD Symptoms and Cognition in Old Adults
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dementia. Participants with scores of 23 or less (which is indicative
of probable dementia [56]) were also excluded from the analyses.
MA adults were not assessed using MMSE since this test was not
designed to provide cognitive data on young or middle-aged adults
and only presents a challenge for older individuals with significant
cognitive difficulties. One MA participant reported taking
medically prescribed dexamphetamine (which is used in ADHD
treatment) and was excluded since information on dosage,
duration of treatment and side effects (such as insomnia and
increased anxiety and irritability) was not available, which could
potentially affect cognitive performance. A final sample of
n = 3443 (50% male) was available for this investigation.
Procedure
Written informed consent for participation in the PATH project
was obtained from all participants according to the ‘National
Statement’ guidelines of the National Health and Medical
Research Council of Australia and following a protocol approved
by the Human Research Ethics Committee of The Australian
National University. For wave 3 of the PATH study, on which the
present analysis is based, all participants were assessed by trained
interviewers to be capable of providing informed consent.
Participants were surveyed once every four years for informa-
tion on physical and mental health, lifestyle and social factors (for
details see [53]). Cognitive assessments were a part of the interview
conducted by trained interviewers. The interview lasted for
approximately 2 hours although this varied between individuals
and was somewhat longer in the older-age group. The assessment
was designed to alternate between questionnaire items, psycho-
metric measures, and anthropometrical measures so as to decrease
the effects of fatigue and attention lapses. A tea break was also
offered in the middle of the assessment. In addition, to minimize
the effects of fatigue and attention on sensitive measures, task
presenting most difficulty were performed early in the interview.
Measures
The short form of the ASRS was used, which consists of a
checklist of six questions regarding symptoms of ADHD based on
the diagnostic criteria of DSM-IV [54,55]. The items in the ASRS
questionnaire are shown in Table S1 in File S1. Each item requires
participants to rate how frequently they experienced a particular
symptom of ADHD in the past six months on a five-point response
scale from ‘‘never’’ [0] to ‘‘very often’’ [4]. A summary score
(ASRS-6 score) with a possible range of 0–24 was obtained as an
equally weighted sum of response scores for all questions. Higher
scores indicate increased risk of ADHD. This screening tool has
performed well in validation studies (sensitivity = 68.7% and
specificity = 99.5%) and has high concordance with clinician
diagnosis (area under the receiver operator curve of 0.90) [55].
Factor analysis of the ASRS reported previously [57] suggest that
the screener is a two-dimensional measure rather than a single
unitary measure. Items 1 to 4 relate to inattention symptoms and
load on one factor (inattentiveness) and items 5 and 6 load on a
second factor (hyperactivity) [57].
Depression and anxiety symptoms were assessed using the
Patient Health Questionnaire (PHQ). This is a short version of the
patient questionnaire component of the Primary Care Evaluation
of Mental Disorders (PRIME-MD) instrument [58,59]. We
generated measures of depression and anxiety-related disorders
from: 9 items related to depression symptoms [rated on a 4-point
scale from ‘‘not at all’’ (1) to ‘‘nearly every day’’ (4)]; 7 items
related to anxiety symptoms [rated on a 3-point scale from ‘‘not at
all’’ (1) to ‘‘more than half the days’’ (3)]; and 5 items related to
panic disorder [rated on a 2-point scale of ‘‘no’’ (1) and ‘‘yes’’ (2)]
following the coding algorithm provided in the PHQ instruction
manual (available from Patient Health Questionnaire Screeners;
http://www.phqscreeners.com/overview.aspx). Variables for pan-
ic disorder and other anxiety syndromes were combined to
generate a binary categorical variable for anxiety symptoms [both
panic disorder and other anxiety syndrome absent (0), either panic
disorder or other anxiety syndrome present (1)].
Cognitive Tests
Cognitive data were collected from participants as described
previously [52]. The cognitive performance measures used in this
study include: the Spot-the-Word Test (STW) which is a measure
of verbal ability [60]; the Trail Making Tests A and B (TMT-A
and TMT-B) for visual attention and task-switching [61,62]; the
Symbol-Digit Modalities Test (SMDT) for information processing
speed and attention [63]; immediate and delayed recall of the first
trial of the California Verbal Learning Test [64]; the Digits Span
Backwards (DSB) task from the Wechsler Memory Scale for verbal
working memory [65]; and Simple and Choice Reaction Time
(SRT and CRT) [66]. Further details of the cognitive tests are
provided in Table S2 in File S1. Percentage of missing data for the
cognitive tests were as follows: Spot-the-Word Test (4.2%), Trail
Making Test (Part A) (2.6%), Trail Making Test (Part B) (2.9%),
Symbol-Digit Modalities Test (2.6%), Immediate Recall (1.7%),
Delayed Recall (1.8%), Digits Span Backwards (2.2%), Simple
Reaction Time (4.7%) and Choice Reaction Time (4.7%).
Statistical Analysis
All statistical analyses were conducted using SPSS 18 and Amos
version 20 (Chicago: SPSS Inc.). Missing data for cognitive
measures were imputed using Expectation-Maximization method
in SPSS. Means and standard deviations were computed for the
ASRS-6 and cognitive test scores. As recommended [54,55],
participants were grouped into four strata based on ASRS-6 with
the following score ranges: 0–9 (stratum I), 10–13 (stratum II), 14–
17 (stratum III) and 18–24 (stratum IV). Comparisons between
MA and OA were performed using Student’s t-tests and Pearson’s
Chi-square tests for the continuous and categorical ASRS
measures respectively (Table 1). For each cognitive test z-scores
were generated. Higher scores on TMT and RT tasks indicate a
worse performance, while a higher score on all other tests indicate
better cognitive function. Pearson correlations were computed for
the ASRS latent factors and cognitive test scores (Tables S3 and S4
in File S1).
We used multi-group structural equation modelling to test cross-
group invariance of the ASRS factor structure (Aim 1) and
compare ADHD symptom–cognition relationships in MA and OA
groups (Aim 2). First, cross-group invariance of the ASRS factor
structure was tested using latent factor SEM in the framework of
confirmatory factor analysis [67]. Equivalence of ASRS across
cohorts was examined according to the procedure outlined in [67].
Once the ASRS factor structures for both cohorts were
determined, a second set of SEMs was generated, which included
the ASRS latent factors, the cognition variables and covariates to
investigate ADHD symptom–cognition relationships. SEMs were
fitted using maximum likelihood methods. Standard errors of the
regression estimates were calculated from 2000 bootstrap-resam-
pled datasets. Model fit was assessed using goodness-of-fit indices
such as tests for chi-square distribution and root-mean square
error of approximation (RMSEA; optimal value ,0.05 [68]);
adjusted goodness of fit index (AGFI; optimal value .0.9 [69]);
comparative fit index (CFI; optimal value .0.9 [70]); Akaike
information criterion (AIC; [71]); Browne-Cudeck criterion (BCC;
[72]). Models with the lowest values for AIC and BCC are
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considered to have the best fit to the data. When sample sizes are
large, as in this study, chi-square statistics can be significant even
when the differences between the models being compared are
small. We therefore also used a range of other goodness-of-fit
indices to obtain a broader assessment of model fit.
Analysis of ASRS factor structure: Previous factor analysis has
established that ASRS measures two correlated constructs,
Inattention and Hyperactivity [57]. We treated these as latent
factors in the SEMs, designated as Inatt (ASRS Items 1–4, Table
S1 in File S1) and Hyperact (ASRS Items 5 and 6, Table S1 in File
S1), respectively. We first tested the validity of the reported two-
factor structure of the ASRS for the MA and OA cohorts
individually (Table 2; Models MA and OA). We then examined
the equivalence of the two-factor structure in both cohorts
simultaneously through a series of models (Table 2; Models 1–6)
with different parameters constrained. Model 1 was the baseline
model where all parameters were allowed to vary between the two
cohorts. For the other models the followings constraints were
applied: Model 2– factor loadings (FL); Model 3– FL, variance of
both factors (FV) and covariance between factors (FC); Model 4–
FL and FC; Model 5a – FL, FC and variance of Inatt (VInatt);
Model 5b – FL, FC and variance of Hyperact (VHyperact); and Model
6: FL, FC and residual variance (RV) of the ASRS items. Since the
more constrained models were nested within the initial model, the
Likelihood Ratio Test (difference in Chi-square statistics relative to
the change in degrees of freedom) along with other goodness-of-fit
indices (see above) was used to select the more parsimonious
model.
Analysis of ADHD symptom–cognition relationships: SEMs
generated for assessing the effect of ASRS latent factors on
cognitive performance included cognitive test scores as dependent
variables and Inatt, Hyperact, sociodemographic variables and
mood-disorder symptoms as predictors. A schematic representa-
tion of our theoretical model is shown in Figure 1A. Factor
Table 1. Socio-demographic characteristics and measures of ADHD, anxiety and depression symptom and cognitive performance
in the sample.
MA (n=1907) OA (n=1536)
Mean (SD)/freq Std. Res Mean (SD)/freq Std. Res t/x2 df p
Gender 7.365 1 0.007
Males 907 (47.6%) 21.3 802 (52.2%) 1.4
Females 1000 (52.4%) 1.3 734 (47.8%) 1.4
Age (years) 50.7 (1.5) 70.6 (1.5) 2386.499 3441 ,0.001
Education (years) 14.9 (2.2) 14.1 (2.6) 9.690 3441 ,0.001
ASRS-6 score 8.15 (3.40) 6.80 (3.25) 11.824 3441 ,0.001
ASRS strata 89.324 3 ,0.001
I 1291 (67.7%) 23.1 1251 (81.4%) 3.5
II 499 (26.2%) 4.1 251 (16.3%) 24.6
III 99 (5.2%) 3.3 29 (1.9%) 23.7
IV 18 (0.9)% 1.5 5 (0.3%) 21.6
ASRS score categories 31.203 1 ,0.001
0–13 1790 (93.9%) 20.8 1502 (97.8%) 0.9
14–24 117 (6.1%) 3.6 34 (2.2%) 24.1
Depression symptoms present 24.620 1 ,0.001
Yes 258 (13.5%) 3.1 126 (8.2%) 23.5
No 1644 (86.2%) 21.1 1410 (91.8%) 1.2
Anxiety symptoms present 19.227 1 ,0.001
Yes 106 (5.6%) 2.9 39 (2.5%) 23.2
No 1801 (94.4%) 20.6 1497 (97.5%) 0.7
Spot-the-Word Testa 51.77 (4.98) 53.27 (4.92) 28.800 3441 ,0.001
Trail Making Test-A (seconds)b 25.78 (7.35) 35.55 (12.34) 228.813 3441 ,0.001
Trail Making Test-B (seconds)b 57.40 (20.13) 82.57 (31.83) 228.230 3441 ,0.001
Simple Reaction Time (seconds)b 0.24 (0.05) 0.28 (0.07) 221.618 3441 ,0.001
Choice Reaction Time (seconds)b 0.30 (0.04) 0.34 (0.05) 228.206 3441 ,0.001
Immediate Recalla 8.18 (2.17) 6.70 (2.21) 19.637 3441 ,0.001
Delayed Recalla 7.38 (2.37) 5.98 (2.32) 17.401 3441 ,0.001
Symbol-Digit Modalities Testa 59.73 (8.54) 48.58 (8.79) 37.595 3441 ,0.001
Digit Span Backwardsa 5.75 (2.29) 5.17 (2.17) 7.578 3441 ,0.001
MA: middle-age cohort; OA: older-age cohort; ASRS: adult ADHD Self-Report Scale; freq: frequency; Std. Res: standardised residuals.
anumber of correct responses;
btime taken to complete.
doi:10.1371/journal.pone.0086552.t001
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loadings of the ASRS items on Inatt and Hyperact and covariance
between the factors were constrained to be equal across both
groups. All other parameters were estimated freely. To avoid
multi-collinearity we used separate models for cognitive variables
(Immediate Recall vs. Delayed Recall and Simple Reaction Time
vs. Choice Reaction Time) that were highly correlated (r.0.7;
Tables S3 and S4 in File S1). Model refinement was guided by
comparison of goodness of fit statistics as described above, with
non-significant paths (p.0.1) removed to improve the overall
parsimony of the models. Only the final, most-parsimonious model
and the coefficients of significant paths are reported. Results were
considered significant at p#0.05.
We also analysed the factor structure of the cognitive tests used
in the study. The factor structure that represents the best fit to
both cohorts are shown in Figure S1. We generated SEM models
with the cognition latent factors as dependent variables using the
method outlined above. These results are presented as Table S5 in
File S1 and Figure S2.
Results
Demographic characteristics, symptom measures for ADHD,
depression and anxiety, and cognitive test scores for both cohorts
are presented in Table 1 (Information about access to data is
available at: http://crahw.anu.edu.au/research/projects/
personality-total-health-path-through-life/data). The OA cohort
reported significantly lower levels for ADHD, depression and
anxiety. For the ASRS, 2.2% of participants in the OA cohort
scored 14 or above, which has previously been identified as
indicative of ADHD diagnosis [55], compared with 6.1% in the
MA cohort. The OA cohort also has fewer individuals classified in
the II, III and IV ASRS strata than the MA cohort. OA
participants performed significantly worse than MA participants in
all cognitive tests with the exception of the Spot-the-Word Test of
verbal ability.
Equivalence of ASRS Instrument in MA and OA Cohorts
The data are well described by models incorporating the
proposed two-factor (Inatt+Hyperact) ASRS structure in both
cohorts individually (Table 2, Models MA and OA). Factor
loadings and factor covariance are presented in Figure 1 for MA
(panel B) and OA (panel C) adults. The covariance between the
latent factors – Inatt and Hyperact was lower in the OA adults
compared to MA adults. The two-factor model also had
acceptable goodness-of-fit indices (Table 2) when both cohorts
were combined (Table 2: Model 1). When FLs for the OA cohort
were constrained to be equal to those estimated for MA adults, the
fit indices changed only slightly (Table 2: Model 2). For an
increase in 4 degrees of freedom in Model 2 compared to Model 1
the corresponding change in x2 was not significant at an alpha
level of 0.05. Constraining FLs, FVs and FC to be the same across
groups (Table 2: Model 3) also resulted in a well-fitting model.
However, the Likelihood Ratio Test indicated that this model was
significantly different from Model 2, suggesting that the variance
and covariance of the latent factors differed significantly between
the age cohorts. To examine this further, we constrained only FC
(Table 2: Model 4) and found the model not to be significantly
different from Model 2, which suggests that while the covariance
between Inatt and Hyperact was lower in the OA cohort it was not
significantly different from the MA cohort. Adding further
constraints on the variances of either Inatt or Hyperact (Table 2:
Model 5a and b) or residual variances of the ASRS items (RVs;
Table 2: Model 6) caused significant changes in model fit
compared to Model 4. This indicates that both the variance of
the latent factors and residual variances of the ASRS items differed
significantly between the age cohorts. Thus, Model 4 where FLs
and FC were constrained to have the same values across cohorts
exhibited the best fit to the data for both age groups and hence,
only this model was used for subsequent analyses.
Table 2. Goodness-of-fit statistics from single cohorts (MA, OA) and multi-group (MA+OA) SEMs assessing the ASRS factor
structure.
Model Constraints x2 df RMSEA AGFI CFI AIC BCC Dx2 Ddf Dp
Individual group analyses
MA 2 46.386 9 0.047 0.981 0.984 70.386 70.474 2 2 2
OA 2 68.586 9 0.065 0.965 0.958 92.586 92.695 2 2 2
Multi-group analyses
1 Nil 111.325 18 0.039 0.974 0.975 159.235 159.524 2 2 2
2 FL 112.065 22 0.034 0.979 0.976 152.065 152.231 0.740a 4 0.946
3 FL+FV+FC 131.554 25 0.035 0.978 0.972 165.554 165.695 19.489b 3 ,0.001
4 FL+FC 113.609 23 0.034 0.980 0.976 151.609 151.767 1.544b 1 0.214
5a FL+FC+VInatt 125.063 24 0.035 0.978 0.973 161.063 161.212 11.454c 1 ,0.001
5b FL+FC+VHyperact 119.023 24 0.034 0.979 0.975 155.023 155.172 5.414c 1 0.020
6 FL+FC+RV 158.245 28 0.037 0.976 0.966 186.245 186.361 44.636c 5 ,0.001
MA: middle-age cohort; OA: older-age cohort; FL: Factor loadings of ASRS items on Inatt and Hyperact latent factors; FV: Factor variance for Inatt and Hyperact; FC:
Covariance between Inatt and Hyperact; VInatt: Variance of Inatt; VHyperact: Variance of Hyperact; RV: Residual Variance of ASRS items.
RMSEA: root-mean square error of approximation (optimal value ,0.05); AGFI: adjusted goodness of fit index (optimal value .0.9); CFI: comparative fit index (optimal
value .0.9); AIC: Akaike information criterion; BCC: Browne-Cudeck criterion. Models with the lowest values for AIC and BCC are considered to have the best fit to the
data.
acompared to Model 1;
bcompared to Model 2;
ccompared to Model 4.
doi:10.1371/journal.pone.0086552.t002
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Effect of ADHD Symptoms on Cognitive Performance
Using multi-group SEMs we investigated the effects of ADHD
symptoms on cognitive performance, while controlling for
sociodemographic variables and mood disorder symptoms
(Figure 1A). The ASRS two-factor model (Model 4) described
above was included as a measure of ADHD symptoms. The
cognitive outcome variables were – Spot-the-Word Test, Trail
Making Test, Symbol-Digit Modalities Test, Choice Reaction
Time, Delayed Recall and Digits Span Backwards. The baseline
model evaluated the theoretical model shown in Figure 1A and
had acceptable model fit indices: x2 = 625.265, df= 125, p,0.001;
RMSEA = 0.034; AGFI = 0.947; CFI = 0.955; AIC = 1061.265;
BCC = 1066.173. However, coefficients for several paths in the
model were not significant. Hence, regression paths with p.0.1
were removed to give a final model with improved overall fit to the
data (x2 = 682.882, df= 189, p,0.001; RMSEA = 0.028;
AGFI = 0.961; CFI = 0.956; AIC = 989.882; BCC = 992.342).
Significant paths (p#0.01) in the final model are shown in
Figures 2 and 3 and regression coefficients are presented in
Table 3. Models with Immediate-recall and Simple Reaction
Time are not reported since they were not significantly associated
with the ADHD latent variables in either cohort.
Inatt and Hyperact have limited direct effects on cognitive
performance. The most notable was a positive association,
observed in both cohorts, between Inatt and Spot-the-Word Test,
implying that higher levels of inattention symptoms are associated
with greater verbal intelligence. Inatt was also positively associated
with Choice Reaction Time, i.e., with slower reaction time in the
MA cohort. Hyperact was positively associated with the Delayed
Recall test (i.e. poor performance) on the MA cohort and Trail
Making Test (Part B) (i.e. better performance) in the OA cohort.
Inatt was associated with depression and anxiety symptoms more
strongly in the MA than the OA cohort.
We also investigated the association between ADHD symptoms
and latent variables obtained from factor analysis of the cognitive
test scores. Factor analysis identified four latent factors (Figure S1)
broadly representing: working memory, information processing
speed, speed/executive function and verbal memory. The most
parsimonious model obtained from the SEM analysis with the
cognition latent factors as dependent variables fit the data well for
both cohorts (Table S5 in File S1 and Figure S2) and was very
similar to the model described in Table 3 and Figures 2 and 3. It is
important to note that the cognition tests were included in the
PATH study only as indicators of different kinds of cognitive
ability and were not designed to measure latent constructs. Hence,
cognitive domains represented by these latent factors are both
difficult to interpret and would not be considered stable as they
have less than three indicators.
Figure 1. Theoretical model for ADHD symptom–cognition relationships and the factor structure of the ASRS. A) The theoretical model
for ADHD symptom–cognition relationships examined in multi-group SEM analysis. Demographic variables include gender, age and education.
Anxiety and depression symptom measures are indicated as the mental health variable in the diagram. B) and C) Models representing the ASRS factor
structure in MA cohort (B) and OA cohort (C). Standardised factor loadings and covariance between the latent factors – Inatt and Hyperact are shown.
Arrows reflect direction of relationships between variables.
doi:10.1371/journal.pone.0086552.g001
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Group Differences in Sociodemographic Variables
The effect of the covariates was similar in the two cohorts, but
there were some notable differences. Gender was strongly
associated with mood variables and marginally with Inatt only in
the MA cohort. It had an effect on the Trail Making Test (Part A)
in the OA cohort and had no effect on any of the cognitive
variables in the MA cohort. Effects of age on the cognitive
variables were similar across both cohorts although the effects
were stronger in the OA cohort. A point of contrast was the
significant effect of age on Delayed Recall test on OA cohort that
Figure 2. Final model for ADHD symptom–cognition analyses for MA cohort. Only paths significant at p,0.01 are shown. Arrows reflect
direction of relationships between variables. Standardised regression coefficients are shown. Factor loadings and covariance between the latent
factors – Inatt and Hyperact, which were constrained equal across groups in the analyses, and correlation between cognitive test measures are not
shown for the sake of simplicity. I: item; gen: gender; educ: education; Inatt: latent factor Inattention; Hyperact: latent factor Hyperactivity; DEP:
depression symptom measure; ANX: anxiety symptom measure; STW: Spot-the-Word Test; TMT-A: Trail Making Test A; TMT-B: Trail Making Test B;
SDMT: Symbol-Digit Modalities Test; CRT: Choice Reaction Time; DR: Delayed Recall; DSB: Digit Span Backwards.
doi:10.1371/journal.pone.0086552.g002
Figure 3. Final model for ADHD symptom–cognition analyses for OA cohort. Only paths significant at p,0.01 are shown. Arrows reflect
direction of relationships between variables. Standardised regression coefficients are shown. Factor loadings and covariance between the latent
factors – Inatt and Hyperact, which were constrained equal across groups in the analyses, and correlation between cognitive test measures are not
shown for the sake of simplicity. I: item; gen: gender; educ: education; Inatt: latent factor Inattention; Hyperact: latent factor Hyperactivity; DEP:
depression symptom measure; ANX: anxiety symptom measure; STW: Spot-the-Word Test; TMT-A: Trail Making Test A; TMT-B: Trail Making Test B;
SDMT: Symbol-Digit Modalities Test; CRT: Choice Reaction Time; DR: Delayed Recall; DSB: Digit Span Backwards.
doi:10.1371/journal.pone.0086552.g003
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was absent in the MA cohort. Age was marginally associated with
Hyperact in older adults only. Education had negative effects on
mood variables in both cohorts although the effect on anxiety was
much stronger in the OA cohort. The effect of education on Inatt
was positive in both cohorts and comparatively stronger in the MA
cohort, implying that more education is associated with higher
Table 3. Path coefficients from multi-group SEM analyses of ADHD symptom–cognition relationships.
MA OA
Coefficients1 SE{ p Coefficients1 SE{ p
age R Hyperact 2 2 2 20.034 0.016 0.032
gender R Hyperact 2 2 2 0.093 0.049 0.056
gender R Inatt 20.062 0.032 0.046 2 2 2
education R Inatt 0.035 0.007 ,0.001 0.018 0.007 0.003
gender R anxiety 0.031 0.010 0.002 2 2 2
education R anxiety 20.004 0.003 0.080 20.005 0.002 ,0.001
Inatt R anxiety 0.077 0.014 ,0.001 0.017 0.011 0.056
gender R depression 0.565 0.169 0.001 2 2 2
education R depression 20.205 0.040 ,0.001 20.114 0.028 ,0.001
Inatt R depression 2.463 0.215 ,0.001 1.300 0.172 ,0.001
education R STW 0.154 0.009 ,0.001 0.153 0.009 ,0.001
Inatt R STW 0.198 0.034 ,0.001 0.185 0.045 ,0.001
depression R STW 20.015 0.005 0.002 20.030 0.008 ,0.001
age R TMT-A 0.047 0.013 ,0.001 0.060 0.011 ,0.001
gender R TMT-A 20.061 0.035 0.085 20.125 0.032 ,0.001
education R TMT-A 20.038 0.009 ,0.001 20.020 0.007 ,0.001
Inatt R TMT-A 0.062 0.034 0.069 2 2 2
depression R TMT-A 0.011 0.005 0.024 0.029 0.007 ,0.001
age R TMT-B 0.033 0.012 0.006 0.055 0.014 ,0.001
education R TMT-B 20.074 0.010 ,0.001 20.064 0.008 ,0.001
Hyperact R TMT-B 2 2 2 20.035 0.017 0.034
depression R TMT-B 0.012 0.005 0.006 0.039 0.008 ,0.001
age R SDMT 20.040 0.013 0.002 20.053 0.015 ,0.001
gender R SDMT 0.258 0.037 ,0.001 0.170 0.037 ,0.001
education R SDMT 0.060 0.010 ,0.001 0.075 0.009 ,0.001
anxiety R SDMT 20.147 0.069 0.063 2 2 2
depression R SDMT 2 2 2 20.045 0.009 ,0.001
age R CRT 0.028 0.010 0.006 0.036 0.014 0.010
gender R CRT 0.172 0.030 ,0.001 0.234 0.041 ,0.001
education R CRT 20.018 0.008 0.011 2 2 2
Inatt R CRT 0.107 0.028 ,0.001 2 2 2
depression R CRT 2 2 2 0.024 0.008 0.001
age R DR 2 2 2 20.054 0.016 ,0.001
gender R DR 0.475 0.042 ,0.001 0.499 0.047 ,0.001
education R DR 0.069 0.010 ,0.001 0.062 0.009 ,0.001
Inatt R DR 0.079 0.042 0.059 2 2 2
Hyperact R DR 0.045 0.021 0.027 2 2 2
anxiety R DR 20.213 0.112 0.046 2 2 2
depression R DR 20.015 0.007 0.019 20.031 0.008 ,0.001
education R DSB 0.084 0.010 ,0.001 2 2 2
Coefficients for ASRS items, which were same for both cohorts are not shown.
Only paths significant at p,0.1 are shown.
1unstandardised estimate.
{standard errors were computed from 2000 bootstrap-resampled datasets.
MA: middle-age cohort; OA: older-age cohort; Inatt: latent factor Inattention; Hyperact: latent factor Hyperactivity; STW: Spot-the-Word test; TMT-A: Trail Making Test A;
TMT-B: Trail Making Test B; SDMT: Symbol-Digit Modalities Test; CRT: Choice Reaction Time; DR: Delayed Recall; DSB: Digit Span Backwards.
doi:10.1371/journal.pone.0086552.t003
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levels of inattention. Greater levels of depression symptoms were
associated with poorer cognitive performance generally, but the
effect is much stronger in the OA cohort. These results did not
differ significantly when latent factors underlying the cognition
tests were included as dependent variables in the SEM models
(Table S5 in File S1 and Figure S2).
Discussion
In this study we investigated ADHD symptoms in a large
population-based sample of older adults, focussing on their effects
on cognition. Importantly, we established that the underlying
construct of the ADHD screener, ASRS, which has been validated
in young adults, is similar in middle- and older-aged adults. We
could therefore be confident that results obtained using the ASRS
related to the same underlying psychological construct in both age
groups.
Significant findings from the study are: i) older adults reported
fewer/less severe ADHD symptoms compared to middle-aged
adults; ii) the effect of ADHD symptoms on cognitive performance
was weaker in older adults compared to middle-aged adults; iii) in
OA adults the ADHD symptom–cognition relationship was mostly
indirect and mediated through the strong association between
depression symptoms and cognition.
We found that 2.2% of the OA cohort met the suggested cut-off
for the ASRS-6 score that has been linked to clinical diagnosis in
previous studies. This estimate falls within the range of 1–2.5%
ADHD prevalence reported in the literature for older adults
[26,27], and is substantially lower than the estimate for the MA
cohort (6.2%). A previous study [27] had found that older elderly
adults (71–94 years) reported fewer ADHD symptoms compared
to younger elderly adults (60–70 years). Hence, our study
replicated previous findings indicating that, when applying the
criteria developed for young adults, the prevalence of ADHD
symptoms appears to decrease with age. It is important to note
that in DSM-5 the symptom threshold for diagnosis of ADHD in
adults has been reduced. The impact of this change on the
prevalence of ADHD in this age group remains to be investigated.
There may be several reasons for this apparent decline in
ADHD symptom levels in old age. The effects of ADHD may
become less discernable from other general age-related changes.
Thus, even though, as we have demonstrated here, the ASRS
appears to measure variation in the same psychological construct
in old age, it may do so with lower sensitivity. The relative
frequency of people with ADHD in the population will also tend to
decline in old age because they have a relatively lower life
expectancy [27]. Their relative participation rate may also decline
due to the accumulating effects of greater rates of accidents,
substance abuse and mood disorders [73,74].
We did not find any significant gender difference in ADHD
symptoms in older adults. This result is consistent with our
previous observation [75] and that of de Zwaan et al. (2012) [76],
but contrary to a previous reports that found significantly higher
prevalence of ADHD in males [77]. It is known that gender
difference in ADHD prevalence is more extreme in paediatric
samples compared to adolescent and adult samples. Since
childhood referrals are initiated by parents and teachers, girls
without the hyperactivity component of ADHD are less likely to be
clinically diagnosed [78]. In contrast, women experience more
internalizing problems than men [79], which may lead to higher
rates of self-referrals in adulthood. Our results, which are obtained
from a general population sample and are free from clinical
ascertainment bias, suggest that the relative increase in female
ADHD prevalence from childhood to adulthood is not a result of
relative over-diagnosis of women.
We replicated the factor structure of the ASRS reported by
Hesse et al. (2013) [57] in both MA and OA cohorts. Our results
suggest that the ASRS measures similar constructs in both age
groups. The latent factors – Inatt and Hyperact were more strongly
correlated in MA than OA adults, however, this difference was not
statistically significant. In a previous study of two samples of
different age [57], correlation between the latent factors was lower
in the sample with a mean age of 35.5 years than the relatively
younger sample (mean age 24.6 years). Whether this difference
was statistically significant has not been reported. Studies in young
and old adults also suggest that among the different ADHD
subtypes, the frequency of the combined subtype relative to the
other subtypes declines with age [27,80]. Thus, with age,
symptoms of inattention and hyperactivity appear both to decrease
and to occur less frequently in combination.
In both MA and OA cohorts the Spot-the-Word Test, which
measures verbal ability, was positively associated with symptoms of
inattention, an effect that we previously reported for the MA
cohort [52]. The sizes of the effects were similar and remained
significant after controlling for depression symptoms, which were
negatively associated with the Spot-the-Word Test, in both
cohorts. One possible explanation is suggested by a previous
study that found that while ADHD adults performed relatively
poorly on verbal learning tests, they did not lose information at a
greater rate once it was encoded [81]. In older adults, reaction
time was not associated with Inatt, in contrast with the MA cohort,
suggesting that information processing speed is less affected by
symptoms of inattention in older adults.
Surprisingly, in the OA cohort, greater hyperactivity was
associated with better task-switching abilities as measured by the
Trail Making Test (Part B). However, this association did not
reach the more stringent significance threshold of p,0.01. This
might suggest that hyperactivity symptoms in this age-group are
beneficial for certain cognitive activities. It is possible that
hyperactivity symptoms in ageing brains make the system noisier
at the neuronal level. While noise is generally considered
detrimental, under certain circumstances it may aid in processing
of weak stimuli through the phenomenon of stochastic resonance
[82]. The motor and sensory input associated with hyperactivity
could increase noise thus enabling neuronal responses that
otherwise would not occur and resulting in improved responses
to certain tasks. Such improvements are more likely in older brains
since ageing associated neurobiological decline leads to weaker
stimuli. The positive association between hyperactivity and
cognitive performance in older adults is in contrast to previous
reports in younger adults, where ADHD symptoms were related to
worse cognitive outcomes [83]. It is important to note that the
level of hyperactivity in the OA cohort is much less than that
present in younger samples and that the ASRS contains only two
items to detect hyperactivity symptoms. Hence, the positive
association between symptoms of hyperactivity and task-switching
ability in older adults needs to be investigated in future studies.
Our results suggest that the effects of ADHD symptoms are
specific to particular cognitive domains, in contrast to a previous
study by Biederman et al (2011) [50] that reported consistent poor
performance across a neuropsychological battery (assessing exec-
utive functions, learning and memory) in non-medicated ADHD
patients. This difference may reflect important differences between
the two studies. The previous study [50] was based on referred
ADHD patients, who were on average younger than our sample. It
reported cognitive effects of ADHD diagnosis and did not include
comorbid mood disorders. Participants in our study were recruited
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randomly from the community and were not selected for ADHD.
We investigated the effects of the full range of ADHD symptom
levels rather clinical diagnosis and we differentiated between
symptoms of inattention and hyperactivity and made adjustments
for symptoms of anxiety and depression, which are common
comorbidities of ADHD.
Our results suggest that inattention symptoms affect cognitive
performance indirectly through their effect on depression in the
OA cohort. Inatt was strongly associated with depression symptoms
in both cohorts, and depression symptoms predict worse
performance in all cognitive tests in the OA cohort but not in
the MA cohort. We also found evidence of statistical mediation of
Inatt on Symbol-Digit Modalities Test by depression in OA adults
since the negative association between Inatt and Symbol-Digit
Modalities Test became non-significant when depression symp-
toms were included in the model. Depression symptoms were also
significantly associated with Symbol-Digit Modalities Test in OA
adults. Thus, our results emphasise the importance of controlling
for comorbid mood disorders when investigating ADHD symp-
tom–cognition relationship, especially in older adults.
The strengths of this study are that it was conducted in a large
representative population sample, and hence it is likely to be free
of the biases that can be associated with clinical and convenience
samples. Furthermore, the narrow age range of the sample
removes the possible confounding effects of age within each
cohort. Consequently, our results are likely to be generalisable to
MA and OA populations. Our study included age groups that
have not been well studied with respect to ADHD symptoms and
thus is a significant addition to the growing literature in this area.
We focus on cognitive performance and ADHD symptoms
highlighting differences between middle- and old-age, which is
important for understanding age-related cognitive change. Finally,
we have modelled both direct ADHD symptom-cognition
relationships and indirect effects mediated by symptoms of
depression, demonstrating age-group differences in these direct
and indirect pathways.
Limitations of the study include lack of clinical assessments for
ADHD, depression and anxiety. In addition, symptom measures
are based on self-reports, which may not be completely accurate
(e.g. social desirability and current emotional state could introduce
biases [84,85]). However, the assessment instruments we used have
been shown to have good sensitivity and specificity and they have
been used in a number of previous studies and validated in
different cultural settings [55,58,86–88]. Furthermore, we have
included appropriate statistical evaluation to ensure that the ASRS
measure is equivalent in MA and OA cohorts. A small number of
cognitive tests have been analysed in the study. These tests were
included in the PATH study as indicators of different abilities and
were not designed to measure latent constructs. Hence, detailed
analysis on the effect of ADHD symptoms on specific cognitive
domains was not possible. Although we found evidence of
statistical mediation by symptoms of depression on ADHD
symptom–cognition relationships, due to the cross-sectional nature
of the study we could not ascertain the causal relation between
symptoms of ADHD and depression. Longitudinal follow-up of the
cohort may contribute towards understanding the temporal
relationships among these factors.
In conclusion, we have shown that although ADHD symptoms
persist, they are less common in older compared to middle-aged
adults. The relationship between ADHD symptoms and cognitive
performance changes with age. While symptoms of depression are
lower in older adults, they are much stronger predictors of
cognitive performance and appear to mediate the effect of ADHD
symptoms on cognition in this age group. Thus, better diagnosis
and treatment of comorbid ADHD and mood disorders in older
adults is required and might contribute to promoting cognitive
health in late-life.
Supporting Information
Figure S1 Models representing the latent structure of the
cognitive tests used in the study in the MA (A) and OA (B)
cohorts. Standardised factor loadings are shown. IR: Immediate
Recall; DR: Delayed Recall; SRT: Simple Reaction Time; CRT:
Choice Reaction Time; TMT-A: Trail Making Test A; TMT-B:
Trail Making Test B; SDMT: Symbol-Digit Modalities Test;
STW: Spot The Word test; DSB: Digit Span Backwards.
(TIF)
Figure S2 Final model for ADHD symptom–cognition analyses
for MA (A) and OA (B) cohorts. Only paths significant at p,0.05
are shown. Arrows reflect direction of relationships between
variables. Standardised regression coefficients are shown. gen:
gender; educ: education; Inatt: latent factor Inattention; Hyperact:
latent factor Hyperactivity; DEP: depression symptom measure;
ANX: anxiety symptom measure. Indicators of the latent variables
are not shown for the sake of clarity.
(TIF)
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